MYOM3 and muscular dystrophy: A truncating mutation in MYOM3, which encodes for myomesin-3 in humans, was recently suggested to be a candidate gene for dilated cardiomyopathy [136] and fragments of myomesin-3 in serum were suggested as a biomarker for muscular dystrophy that may even be more reliable than the generally used creatine kinase [137].